Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT

Watchlist Manager
Arcturus Therapeutics Holdings Inc Logo
Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
Watchlist
Price: 29.78 USD -2.36% Market Closed
Updated: May 20, 2024

Arcturus Therapeutics Holdings Inc
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Arcturus Therapeutics Holdings Inc
Accounts Receivables Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
Accounts Receivables
$27.1m
CAGR 3-Years
138%
CAGR 5-Years
43%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Accounts Receivables
$11.9B
CAGR 3-Years
8%
CAGR 5-Years
16%
CAGR 10-Years
13%
Gilead Sciences Inc
NASDAQ:GILD
Accounts Receivables
$4.7B
CAGR 3-Years
6%
CAGR 5-Years
7%
CAGR 10-Years
4%
Amgen Inc
NASDAQ:AMGN
Accounts Receivables
$6.8B
CAGR 3-Years
15%
CAGR 5-Years
12%
CAGR 10-Years
10%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Accounts Receivables
$1.8B
CAGR 3-Years
22%
CAGR 5-Years
33%
CAGR 10-Years
40%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Accounts Receivables
$5.2B
CAGR 3-Years
8%
CAGR 5-Years
18%
CAGR 10-Years
17%

See Also

What is Arcturus Therapeutics Holdings Inc's Accounts Receivables?
Accounts Receivables
27.1m USD

Based on the financial report for Mar 31, 2024, Arcturus Therapeutics Holdings Inc's Accounts Receivables amounts to 27.1m USD.

What is Arcturus Therapeutics Holdings Inc's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
43%

Over the last year, the Accounts Receivables growth was -71%. The average annual Accounts Receivables growth rates for Arcturus Therapeutics Holdings Inc have been 138% over the past three years , 43% over the past five years .